Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GTP-binding protein Rit2 is a neuron-specific small GTPase belonging to the Ras superfamily, principally regulating neuronal differentiation, survival, and signaling[1][2][5]. RIT2 is tightly expressed in various neuronal populations—including retinal, dopaminergic, and other neurons—in both the central and peripheral nervous system[2]. It interacts with the dopamine transporter and modulates its internalization in specialized membrane microdomains, impacting dopaminergic signaling, and is implicated in neurotrophin-mediated differentiation via activation of b-Raf and p38 MAP kinase signaling cascades[1][2]. RIT2 also modulates neuronal gene transcription through interactions with transcription factors such as Brn-3a/POU4F1[2][5]. Genetic studies link RIT2 to Parkinson’s disease risk and suggest involvement in schizophrenia and other neuropsychiatric disorders[2][3][5]. No approved drugs directly target RIT2; mechanisms for RIT2 modulation for therapeutic purposes remain an avenue for research.
Not established for drugs, as there are no drugs targeting RIT2 directly described in current biomedical literature
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GTP-binding protein Rit2 (RIT2).